Refresh

Sun Pharma Advanced Research Company Ltd. - Research Center

532872 SPARC Group (A) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

238.78 137.25 252.96 76.81 182.87
Expenses

Material consumed

27.27 22.65 22.65 27.90 15.33

Manufacturing expenses

287.16 183.91 251.99 174.44 152.98

Personnel expenses

107.00 96.78 91.59 93.09 81.06

Selling expenses

- - - - -

Adminstrative expenses

31.41 20.67 21.71 91.41 84.79

Expenses capitalised

- - - - -

Cost of sales

452.84 324.00 387.93 386.83 334.16

Operating profit

-214.06 -186.75 -134.98 -310.01 -151.29

Other recurring income

10.88 6.84 5.41 9.76 13.51

Adjusted PBDIT

-203.18 -179.90 -129.57 -300.25 -137.78

Financial expenses

7.63 13.33 10.65 2.67 0.09

Depreciation

11.77 10.16 10.92 9.48 7.55

Other write offs

- - - - -

Adjusted PBT

-222.58 -203.40 -151.14 -312.40 -145.43

Tax charges

- - - - -

Adjusted PAT

- - - - -

Non recurring items

1.35 1.70 1.53 -2.47 0.71

Other non cash adjustments

- - - - -

Reported net profit

-221.23 -201.70 -149.61 -314.87 -144.72

Earnigs before appropriation

-1,591.81 -1,370.58 -1,168.88 -1,019.27 -685.63

Equity dividend

- - - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

-1,591.81 -1,370.58 -1,168.88 -1,019.27 -685.63
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com